Global Peripheral Artery Disease Market Size to Hit USD 10.8 billion by 2035 with 7.7% CAGR Growth

Allied Market Research published a report, titled, "Peripheral Artery Disease Market by Product Type (Devices and Drugs), and End User (Hospitals and Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "peripheral artery disease market" was valued at $4.5 billion in 2023, and is estimated to reach $10.8 billion by 2035, growing at a CAGR of 7.7% from 2024 to 2035.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

The peripheral artery disease market is expected to grow significantly owing to rise in the prevalence of peripheral artery disease, surge in the geriatric population, and rise in the adoption of minimal invasive procedures. Furthermore, technological advancement in peripheral artery disease treatment devices is expected to present significant growth opportunities in the peripheral artery disease market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/4315

𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: -

• Philips N.V.
• Braun Melsungen AG
• Medtronic
• Bayer AG
• Boston Scientific Corporation
• Becton Dickinson and Company
• Terumo Medical Corporation
• Biotronik
• Cardinal Health
• Abbott

The report provides a detailed analysis of these key players in the peripheral artery disease market. These players have adopted different strategies such as product approval, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario

𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐢𝐩𝐡𝐞𝐫𝐚𝐥 𝐀𝐫𝐭𝐞𝐫𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: -

By product type, the drug segment held the highest market share in 2023 and is expected to dominate during the forecast period, accounting for three-fifths of the peripheral artery disease market revenue, owing to the regular need of drugs to control blood cholesterol levels to avoid progression of peripheral artery disease.

By end user, the hospitals segment held the highest market share in 2023, accounting for more than half of peripheral artery disease market revenue owing to peripheral artery disease often requiring complex diagnostic procedures, medical management, and interventional treatments such as angioplasty, stenting, or bypass surgery. Hospitals are equipped with the necessary infrastructure, including specialized imaging facilities, operating rooms, and skilled medical professionals, to deliver these treatments effectively.

However, the specialty clinics segment is expected to register the highest CAGR during the forecast period, owing to specialty clinics being typically more efficient and cost-effective than hospitals for certain peripheral artery disease related services. With lower overhead costs and streamlined processes, specialty clinics can provide high-quality care at competitive prices, appealing to patients and payers alike.

By region, North America held the highest market share in 2023, accounting for more than one-third of peripheral artery disease market revenue. This is attributed to the strong presence of key players in the region, well-developed healthcare infrastructure, and rise in the prevalence of peripheral artery disease. However, Asia-Pacific is expected to register a noteworthy CAGR during the forecast period, owing to rise in the geriatric population and surge in the prevalence of cardiovascular disease.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/4315

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.